Cargando…

COVID-19 vaccine uptake among people who inject drugs in Tijuana Mexico

BACKGROUND: SARS-CoV-2 prevalence is elevated among people who inject drugs (PWID). In Tijuana, Mexico, COVID-19 vaccines became available to the general population in June 2021, but uptake among PWID was <10%. We studied COVID-19 vaccine uptake among PWID in Tijuana following implementation of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Harvey-Vera, Alicia, Munoz, Sheryl, Artamonova, Irina, Abramovitz, Daniela, Mittal, Maria Luisa, Rosales, Cecilia, Strathdee, Steffanie A., Rangel, Maria Gudelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485825/
https://www.ncbi.nlm.nih.gov/pubmed/36148330
http://dx.doi.org/10.3389/fpubh.2022.931306
_version_ 1784792148292403200
author Harvey-Vera, Alicia
Munoz, Sheryl
Artamonova, Irina
Abramovitz, Daniela
Mittal, Maria Luisa
Rosales, Cecilia
Strathdee, Steffanie A.
Rangel, Maria Gudelia
author_facet Harvey-Vera, Alicia
Munoz, Sheryl
Artamonova, Irina
Abramovitz, Daniela
Mittal, Maria Luisa
Rosales, Cecilia
Strathdee, Steffanie A.
Rangel, Maria Gudelia
author_sort Harvey-Vera, Alicia
collection PubMed
description BACKGROUND: SARS-CoV-2 prevalence is elevated among people who inject drugs (PWID). In Tijuana, Mexico, COVID-19 vaccines became available to the general population in June 2021, but uptake among PWID was <10%. We studied COVID-19 vaccine uptake among PWID in Tijuana following implementation of a pop-up vaccination clinic. METHODS: Beginning in October, 2020, PWID in Tijuana aged ≥18 years were enrolled into a longitudinal cohort study. At baseline and semi-annually, participants underwent interviewer-administered interviews on health behaviors and COVID-19 exposures through April 5, 2022. From June 21—September 20, 2021, staff referred PWID to a temporary COVID-19 vaccine pop-up clinic that was coincidentally established near the study office. Participants attending the clinic completed a short interview on barriers to vaccination and were offered facilitated access to free Janssen® COVID-19 vaccine. All participants were reimbursed $5 for this interview, regardless of whether or not they chose to be vaccinated. Poisson regression was used to evaluate the effect of the pop-up clinic on COVID-19 vaccination uptake, controlling forpotential confounders. RESULTS: Of 344 participants, 136 (39.5%) reported having received at least one COVID-19 vaccine dose during the 10 months follow-up period, of whom 113 (83.1%) received vaccine at the pop-up clinic and 23 (16.9%) elsewhere. One third of those receiving COVID-19 vaccine during the pop-up clinic were previously vaccine hesitant. Attending the pop-up clinic was independently associated with higher rates of COVID-19 vaccination Adjusted Rate Ratio (AdjRR: 9.15; 95% CI: 5.68–14.74). CONCLUSIONS: We observed a significant increase in COVID-19 vaccine uptake associated with attending a temporary pop-up vaccine clinic in Tijuana suggesting that efforts to improve vaccination in this vulnerable population should include convenient locations and staff who have experience working with substance using populations. Since COVID-19 vaccination rates remain sub-optimal, sustained interventions to increase uptake are needed.
format Online
Article
Text
id pubmed-9485825
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94858252022-09-21 COVID-19 vaccine uptake among people who inject drugs in Tijuana Mexico Harvey-Vera, Alicia Munoz, Sheryl Artamonova, Irina Abramovitz, Daniela Mittal, Maria Luisa Rosales, Cecilia Strathdee, Steffanie A. Rangel, Maria Gudelia Front Public Health Public Health BACKGROUND: SARS-CoV-2 prevalence is elevated among people who inject drugs (PWID). In Tijuana, Mexico, COVID-19 vaccines became available to the general population in June 2021, but uptake among PWID was <10%. We studied COVID-19 vaccine uptake among PWID in Tijuana following implementation of a pop-up vaccination clinic. METHODS: Beginning in October, 2020, PWID in Tijuana aged ≥18 years were enrolled into a longitudinal cohort study. At baseline and semi-annually, participants underwent interviewer-administered interviews on health behaviors and COVID-19 exposures through April 5, 2022. From June 21—September 20, 2021, staff referred PWID to a temporary COVID-19 vaccine pop-up clinic that was coincidentally established near the study office. Participants attending the clinic completed a short interview on barriers to vaccination and were offered facilitated access to free Janssen® COVID-19 vaccine. All participants were reimbursed $5 for this interview, regardless of whether or not they chose to be vaccinated. Poisson regression was used to evaluate the effect of the pop-up clinic on COVID-19 vaccination uptake, controlling forpotential confounders. RESULTS: Of 344 participants, 136 (39.5%) reported having received at least one COVID-19 vaccine dose during the 10 months follow-up period, of whom 113 (83.1%) received vaccine at the pop-up clinic and 23 (16.9%) elsewhere. One third of those receiving COVID-19 vaccine during the pop-up clinic were previously vaccine hesitant. Attending the pop-up clinic was independently associated with higher rates of COVID-19 vaccination Adjusted Rate Ratio (AdjRR: 9.15; 95% CI: 5.68–14.74). CONCLUSIONS: We observed a significant increase in COVID-19 vaccine uptake associated with attending a temporary pop-up vaccine clinic in Tijuana suggesting that efforts to improve vaccination in this vulnerable population should include convenient locations and staff who have experience working with substance using populations. Since COVID-19 vaccination rates remain sub-optimal, sustained interventions to increase uptake are needed. Frontiers Media S.A. 2022-09-06 /pmc/articles/PMC9485825/ /pubmed/36148330 http://dx.doi.org/10.3389/fpubh.2022.931306 Text en Copyright © 2022 Harvey-Vera, Munoz, Artamonova, Abramovitz, Mittal, Rosales, Strathdee and Rangel. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Harvey-Vera, Alicia
Munoz, Sheryl
Artamonova, Irina
Abramovitz, Daniela
Mittal, Maria Luisa
Rosales, Cecilia
Strathdee, Steffanie A.
Rangel, Maria Gudelia
COVID-19 vaccine uptake among people who inject drugs in Tijuana Mexico
title COVID-19 vaccine uptake among people who inject drugs in Tijuana Mexico
title_full COVID-19 vaccine uptake among people who inject drugs in Tijuana Mexico
title_fullStr COVID-19 vaccine uptake among people who inject drugs in Tijuana Mexico
title_full_unstemmed COVID-19 vaccine uptake among people who inject drugs in Tijuana Mexico
title_short COVID-19 vaccine uptake among people who inject drugs in Tijuana Mexico
title_sort covid-19 vaccine uptake among people who inject drugs in tijuana mexico
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485825/
https://www.ncbi.nlm.nih.gov/pubmed/36148330
http://dx.doi.org/10.3389/fpubh.2022.931306
work_keys_str_mv AT harveyveraalicia covid19vaccineuptakeamongpeoplewhoinjectdrugsintijuanamexico
AT munozsheryl covid19vaccineuptakeamongpeoplewhoinjectdrugsintijuanamexico
AT artamonovairina covid19vaccineuptakeamongpeoplewhoinjectdrugsintijuanamexico
AT abramovitzdaniela covid19vaccineuptakeamongpeoplewhoinjectdrugsintijuanamexico
AT mittalmarialuisa covid19vaccineuptakeamongpeoplewhoinjectdrugsintijuanamexico
AT rosalescecilia covid19vaccineuptakeamongpeoplewhoinjectdrugsintijuanamexico
AT strathdeesteffaniea covid19vaccineuptakeamongpeoplewhoinjectdrugsintijuanamexico
AT rangelmariagudelia covid19vaccineuptakeamongpeoplewhoinjectdrugsintijuanamexico